March 01, 2023 — 04:11 pm EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Inovio Pharmaceuticals Inc. (INO) revealed Loss for fourth quarter that decreased from the same period last year but  missed the Street estimates.
The company's earnings came in at -$54.5 million, or -$0.22 per share.  This compares with -$106.9 million, or -$0.50 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$0.17 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 84.5% to $0.13 million from $0.84 million last year.
Inovio Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings (Q4): -$54.5 Mln. vs. -$106.9 Mln. last year.
-EPS (Q4): -$0.22 vs. -$0.50 last year.
-Analyst Estimates: -$0.17
-Revenue (Q4): $0.13 Mln vs. $0.84 Mln last year.
 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.